复发/难治性尤文肉瘤局部及转移灶导向治疗的共识建议
针对复发/难治性尤文肉瘤局部/转移灶导向治疗(LMDT)缺乏随机或前瞻性数据、临床实践不确定的现状,本文回顾相关文献并给出共识建议:LMDT应个体化评估时机、方式、姑息或治愈意图及与化疗的关系,放疗可选用标准、大分割或立体定向技术,手术可获取组织,介入放射学也可取材并治疗,决策应多学科并考虑疾病负荷、无进展间期、预期寿命、毒性和生活质量,并与患者及家属共同决策。
要点
- LMDT应个体化评估适宜性、最佳时机/方式、姑息或治愈意图及与化疗的关系。
- 放疗可基于既往放疗、肿瘤大小和/或位置选择标准、大分割或立体定向技术。
- 决策应多学科参与,考虑疾病负荷、无进展间期、预期寿命、毒性和生活质量。
核心结论
- 复发/难治性尤文肉瘤的LMDT应个体化考虑,由多学科团队综合疾病负荷、无进展间期、预期寿命、LMDT毒性谱和生活质量做出决策,并与患者及家属充分知情共同决策。
研究设计与样本
- 共识建议报告,基于对复发/难治性尤文肉瘤LMDT相关文献的回顾制定,原文未报告证据分级方法。
临床应用与阅片要点
- LMDT应逐例评估适宜性、最佳时机/方式、姑息或治愈意图及其与化疗的关系。
- 放疗可基于既往放疗、肿瘤大小和/或位置选择标准、大分割或立体定向技术。
- 化疗可与放疗联合,但复发场景的前瞻性数据有限。
- 手术不仅针对肿瘤,还提供组织供分析,但需考虑基于位置、切除范围和恢复并发症的潜在手术并发症。
- 介入放射学方法可在实施LMDT的同时获取肿瘤组织,具体操作基于位置、大小和病变范围选择;可联合多种LMDT方式。
局限性
- 指导复发/难治性尤文肉瘤LMDT的随机或前瞻性数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Limited randomized or prospective data are available to guide local/metastasis directed therapy (LMDT) in relapsed/recurrent Ewing sarcoma (RR-ES), resulting in uncertainty regarding best clinical practice for these patients. This report reviews the available literature on LMDT approaches and provides consensus recommendations regarding therapeutic decision making, timing, and indications for the use of LMDT in the management of RR-ES. LMDT should be considered on a case-by-case basis to assess appropriateness, optimal timing/modality, palliative versus curative intent, and its role in relation to chemotherapy. One commonly used LMDT is radiotherapy (RT), which can be delivered through standard, hypofractionated, or stereotactic techniques based on factors including prior RT, tumor size, and/or location. Chemotherapy can be combined with RT, although prospective data are limited in the relapse setting. Surgery for LMDT not only addresses the tumor but also provides tissue for analysis, though the potential surgical morbidity based on location, extent of resection, and recovery complications should be considered. Interventional radiology approaches also can procure tumor tissue while delivering LMDT; there are several different procedures available based on the location, size, and extent of disease. Finally, a combination of LMDT approaches can be used for patients with RR-ES. Decisions regarding the management of RR-ES should involve a multidisciplinary team and factor in the burden of disease, progression-free interval, life expectancy, toxicity profiles of LMDT, and quality of life. In such patients, informed and shared decision making with patients and their families is paramount.
引用
- Shah C, Campbell SR, Murphy E, et al. Consensus recommendations regarding local and metastasis-directed therapies in the management of relapsed/recurrent Ewing sarcoma. Cancer. 2025. PMID: 40251761. doi:10.1002/cncr.35858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。